GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)

South Korea flag South Korea · Delayed Price · Currency is KRW
20,450
+300 (1.49%)
Feb 10, 2025, 2:34 PM KST
63.08%
Market Cap 1.29T
Revenue (ttm) 62.73B
Net Income (ttm) -53.33B
Shares Out 39.68M
EPS (ttm) -1,348.76
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 612,931
Average Volume 794,980
Open 22,300
Previous Close 20,150
Day's Range 20,000 - 22,300
52-Week Range 9,060 - 23,500
Beta 0.77
RSI 80.68
Earnings Date Mar 21, 2025

About GemVax&KAEL

GemVax&KAEL Co.,Ltd engages in the manufacturing and selling of coating resins and filters for semiconductors and display production in South Korea. The company offers CA filter and gas scrubber resins for pollution control in the semiconductor and display sectors. It also engages in the research and development of anti-cancer vaccines. The company was founded in 1998 and is headquartered in Daejeon, South Korea. [Read more]

Industry Special Industry Machinery, not elsewhere classified
Founded 1998
Employees 186
Stock Exchange KOSDAQ
Ticker Symbol 082270
Full Company Profile

Financial Performance

In 2023, GemVax&KAEL's revenue was 72.21 billion, a decrease of -4.74% compared to the previous year's 75.80 billion. Losses were -27.18 billion, 38.6% more than in 2022.

Financial Statements

News

There is no news available yet.